Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoster Vaccine Timing After HSCT
NCT03192319Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2017
- Primary completion
- Aug 2018
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Open-label trial of zoster vaccine, live in herpes zoster (HZ) (4 arms), sponsored by Seoul National University Hospital. Primary endpoint: Varicella-zoster virus-specific interferon-gamma ELISPOT response at 6 weeks. Started Jul 2017; status: completed.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT03192319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03192319.